- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Prostate-specific Antigen (PSA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Prostate-specific Antigen (PSA) Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Screening accounting for % of the Prostate-specific Antigen (PSA) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CLIA Method segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Prostate-specific Antigen (PSA) Testing include Abbott, Boston Scientific Corporation, Bayer AG, Siemens Healthcare, and DiaSorin, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prostate-specific Antigen (PSA) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CLIA Method
ELISA Method
Market segment by Application, can be divided into
Screening
Post-treatment Monitoring
Other
Market segment by players, this report covers
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate-specific Antigen (PSA) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate-specific Antigen (PSA) Testing, with revenue, gross margin and global market share of Prostate-specific Antigen (PSA) Testing from 2019 to 2022.
Chapter 3, the Prostate-specific Antigen (PSA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate-specific Antigen (PSA) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Prostate-specific Antigen (PSA) Testing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Prostate-specific Antigen (PSA) Testing
1.2 Classification of Prostate-specific Antigen (PSA) Testing by Type
1.2.1 Overview: Global Prostate-specific Antigen (PSA) Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type in 2021
1.2.3 CLIA Method
1.2.4 ELISA Method
1.3 Global Prostate-specific Antigen (PSA) Testing Market by Application
1.3.1 Overview: Global Prostate-specific Antigen (PSA) Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Global Prostate-specific Antigen (PSA) Testing Market Size & Forecast
1.5 Global Prostate-specific Antigen (PSA) Testing Market Size and Forecast by Region
1.5.1 Global Prostate-specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Prostate-specific Antigen (PSA) Testing Market Size by Region, (2017-2022)
1.5.3 North America Prostate-specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Prostate-specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
1.5.6 South America Prostate-specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate-specific Antigen (PSA) Testing Market Drivers
1.6.2 Prostate-specific Antigen (PSA) Testing Market Restraints
1.6.3 Prostate-specific Antigen (PSA) Testing Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Prostate-specific Antigen (PSA) Testing Product and Solutions
2.1.4 Abbott Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product and Solutions
2.2.4 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Boston Scientific Corporation Recent Developments and Future Plans
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Product and Solutions
2.3.4 Bayer AG Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bayer AG Recent Developments and Future Plans
2.4 Siemens Healthcare
2.4.1 Siemens Healthcare Details
2.4.2 Siemens Healthcare Major Business
2.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product and Solutions
2.4.4 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Siemens Healthcare Recent Developments and Future Plans
2.5 DiaSorin
2.5.1 DiaSorin Details
2.5.2 DiaSorin Major Business
2.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Product and Solutions
2.5.4 DiaSorin Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 DiaSorin Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Prostate-specific Antigen (PSA) Testing Product and Solutions
2.6.4 Roche Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Roche Recent Developments and Future Plans
2.7 Beckman Coulter
2.7.1 Beckman Coulter Details
2.7.2 Beckman Coulter Major Business
2.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product and Solutions
2.7.4 Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Beckman Coulter Recent Developments and Future Plans
2.8 PerkinElmer
2.8.1 PerkinElmer Details
2.8.2 PerkinElmer Major Business
2.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Product and Solutions
2.8.4 PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 PerkinElmer Recent Developments and Future Plans
2.9 Tosoh
2.9.1 Tosoh Details
2.9.2 Tosoh Major Business
2.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Product and Solutions
2.9.4 Tosoh Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Tosoh Recent Developments and Future Plans
2.10 Ortho Clinical
2.10.1 Ortho Clinical Details
2.10.2 Ortho Clinical Major Business
2.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product and Solutions
2.10.4 Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Ortho Clinical Recent Developments and Future Plans
2.11 Fujirebio
2.11.1 Fujirebio Details
2.11.2 Fujirebio Major Business
2.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Product and Solutions
2.11.4 Fujirebio Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Fujirebio Recent Developments and Future Plans
2.12 Mediwatch
2.12.1 Mediwatch Details
2.12.2 Mediwatch Major Business
2.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Product and Solutions
2.12.4 Mediwatch Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Mediwatch Recent Developments and Future Plans
2.13 BodiTech
2.13.1 BodiTech Details
2.13.2 BodiTech Major Business
2.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Product and Solutions
2.13.4 BodiTech Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 BodiTech Recent Developments and Future Plans
2.14 Bristol-Myers Squibb Company
2.14.1 Bristol-Myers Squibb Company Details
2.14.2 Bristol-Myers Squibb Company Major Business
2.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product and Solutions
2.14.4 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.15 GE Healthcare
2.15.1 GE Healthcare Details
2.15.2 GE Healthcare Major Business
2.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Product and Solutions
2.15.4 GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 GE Healthcare Recent Developments and Future Plans
2.16 Endocare
2.16.1 Endocare Details
2.16.2 Endocare Major Business
2.16.3 Endocare Prostate-specific Antigen (PSA) Testing Product and Solutions
2.16.4 Endocare Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Endocare Recent Developments and Future Plans
2.17 Merck＆Co.
2.17.1 Merck＆Co. Details
2.17.2 Merck＆Co. Major Business
2.17.3 Merck＆Co. Prostate-specific Antigen (PSA) Testing Product and Solutions
2.17.4 Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Merck＆Co. Recent Developments and Future Plans
2.18 Medtronic
2.18.1 Medtronic Details
2.18.2 Medtronic Major Business
2.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Product and Solutions
2.18.4 Medtronic Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Medtronic Recent Developments and Future Plans
2.19 Sanofi-Aventis SA
2.19.1 Sanofi-Aventis SA Details
2.19.2 Sanofi-Aventis SA Major Business
2.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product and Solutions
2.19.4 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Sanofi-Aventis SA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate-specific Antigen (PSA) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate-specific Antigen (PSA) Testing Players Market Share in 2021
3.2.2 Top 10 Prostate-specific Antigen (PSA) Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Prostate-specific Antigen (PSA) Testing Players Head Office, Products and Services Provided
3.4 Prostate-specific Antigen (PSA) Testing Mergers & Acquisitions
3.5 Prostate-specific Antigen (PSA) Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate-specific Antigen (PSA) Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application (2017-2022)
5.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2028)
6.2 North America Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2028)
6.3 North America Prostate-specific Antigen (PSA) Testing Market Size by Country
6.3.1 North America Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2028)
6.3.2 United States Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2028)
7.2 Europe Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2028)
7.3 Europe Prostate-specific Antigen (PSA) Testing Market Size by Country
7.3.1 Europe Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2028)
7.3.2 Germany Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7.3.3 France Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Prostate-specific Antigen (PSA) Testing Market Size by Region
8.3.1 Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Region (2017-2028)
8.3.2 China Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8.3.5 India Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2028)
9.2 South America Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2028)
9.3 South America Prostate-specific Antigen (PSA) Testing Market Size by Country
9.3.1 South America Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2028)
9.3.2 Brazil Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Prostate-specific Antigen (PSA) Testing Market Size by Country
10.3.1 Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2028)
10.3.2 Turkey Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Prostate-specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Prostate-specific Antigen (PSA) Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Prostate-specific Antigen (PSA) Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Prostate-specific Antigen (PSA) Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Prostate-specific Antigen (PSA) Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Region (2023-2028)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 9. Abbott Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors
Table 11. Boston Scientific Corporation Major Business
Table 12. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 13. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bayer AG Corporate Information, Head Office, and Major Competitors
Table 15. Bayer AG Major Business
Table 16. Bayer AG Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 17. Bayer AG Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Healthcare Major Business
Table 20. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 21. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 23. DiaSorin Major Business
Table 24. DiaSorin Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 25. DiaSorin Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 29. Roche Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 31. Beckman Coulter Major Business
Table 32. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 33. Beckman Coulter Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 35. PerkinElmer Major Business
Table 36. PerkinElmer Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 37. PerkinElmer Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Tosoh Corporate Information, Head Office, and Major Competitors
Table 39. Tosoh Major Business
Table 40. Tosoh Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 41. Tosoh Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Ortho Clinical Corporate Information, Head Office, and Major Competitors
Table 43. Ortho Clinical Major Business
Table 44. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 45. Ortho Clinical Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 47. Fujirebio Major Business
Table 48. Fujirebio Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 49. Fujirebio Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Mediwatch Corporate Information, Head Office, and Major Competitors
Table 51. Mediwatch Major Business
Table 52. Mediwatch Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 53. Mediwatch Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. BodiTech Corporate Information, Head Office, and Major Competitors
Table 55. BodiTech Major Business
Table 56. BodiTech Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 57. BodiTech Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 59. Bristol-Myers Squibb Company Major Business
Table 60. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 61. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 63. GE Healthcare Major Business
Table 64. GE Healthcare Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 65. GE Healthcare Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Endocare Corporate Information, Head Office, and Major Competitors
Table 67. Endocare Major Business
Table 68. Endocare Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 69. Endocare Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Merck＆Co. Corporate Information, Head Office, and Major Competitors
Table 71. Merck＆Co. Major Business
Table 72. Merck＆Co. Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 73. Merck＆Co. Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Medtronic Corporate Information, Head Office, and Major Competitors
Table 75. Medtronic Major Business
Table 76. Medtronic Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 77. Medtronic Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Sanofi-Aventis SA Corporate Information, Head Office, and Major Competitors
Table 79. Sanofi-Aventis SA Major Business
Table 80. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product and Solutions
Table 81. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Global Prostate-specific Antigen (PSA) Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 83. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 84. Breakdown of Prostate-specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Prostate-specific Antigen (PSA) Testing Players Head Office, Products and Services Provided
Table 86. Prostate-specific Antigen (PSA) Testing Mergers & Acquisitions in the Past Five Years
Table 87. Prostate-specific Antigen (PSA) Testing New Entrants and Expansion Plans
Table 88. Global Prostate-specific Antigen (PSA) Testing Revenue (USD Million) by Type (2017-2022)
Table 89. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Type (2017-2022)
Table 90. Global Prostate-specific Antigen (PSA) Testing Revenue Forecast by Type (2023-2028)
Table 91. Global Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022)
Table 92. Global Prostate-specific Antigen (PSA) Testing Revenue Forecast by Application (2023-2028)
Table 93. North America Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 94. North America Prostate-specific Antigen (PSA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 95. North America Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 96. North America Prostate-specific Antigen (PSA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 97. North America Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 98. North America Prostate-specific Antigen (PSA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 99. Europe Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 100. Europe Prostate-specific Antigen (PSA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 101. Europe Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 102. Europe Prostate-specific Antigen (PSA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 103. Europe Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 104. Europe Prostate-specific Antigen (PSA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 105. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 106. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 107. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 108. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 109. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Region (2017-2022) & (USD Million)
Table 110. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue by Region (2023-2028) & (USD Million)
Table 111. South America Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 112. South America Prostate-specific Antigen (PSA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 113. South America Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 114. South America Prostate-specific Antigen (PSA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 115. South America Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 116. South America Prostate-specific Antigen (PSA) Testing Revenue by Country (2023-2028) & (USD Million)
Table 117. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Type (2017-2022) & (USD Million)
Table 118. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Type (2023-2028) & (USD Million)
Table 119. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Application (2017-2022) & (USD Million)
Table 120. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Application (2023-2028) & (USD Million)
Table 121. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Country (2017-2022) & (USD Million)
Table 122. Middle East & Africa Prostate-specific Antigen (PSA) Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Prostate-specific Antigen (PSA) Testing Picture
Figure 2. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Type in 2021
Figure 3. CLIA Method
Figure 4. ELISA Method
Figure 5. Prostate-specific Antigen (PSA) Testing Revenue Market Share by Application in 2021
Figure 6. Screening Picture
Figure 7. Post-treatment Monitoring Picture
Figure 8. Other Picture
Figure 9. Global Prostate-specific Antigen (PSA) Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Prostate-specific Antigen (PSA) Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Region (2017-2028)
Figure 12. Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Region in 2021
Figure 13. North America Prostate-specific Antigen (PSA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Prostate-specific Antigen (PSA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Prostate-specific Antigen (PSA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Prostate-specific Antigen (PSA) Testing Market Drivers
Figure 19. Prostate-specific Antigen (PSA) Testing Market Restraints
Figure 20. Prostate-specific Antigen (PSA) Testing Market Trends
Figure 21. Abbott Recent Developments and Future Plans
Figure 22. Boston Scientific Corporation Recent Developments and Future Plans
Figure 23. Bayer AG Recent Developments and Future Plans
Figure 24. Siemens Healthcare Recent Developments and Future Plans
Figure 25. DiaSorin Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Beckman Coulter Recent Developments and Future Plans
Figure 28. PerkinElmer Recent Developments and Future Plans
Figure 29. Tosoh Recent Developments and Future Plans
Figure 30. Ortho Clinical Recent Developments and Future Plans
Figure 31. Fujirebio Recent Developments and Future Plans
Figure 32. Mediwatch Recent Developments and Future Plans
Figure 33. BodiTech Recent Developments and Future Plans
Figure 34. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 35. GE Healthcare Recent Developments and Future Plans
Figure 36. Endocare Recent Developments and Future Plans
Figure 37. Merck＆Co. Recent Developments and Future Plans
Figure 38. Medtronic Recent Developments and Future Plans
Figure 39. Sanofi-Aventis SA Recent Developments and Future Plans
Figure 40. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Players in 2021
Figure 41. Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Prostate-specific Antigen (PSA) Testing Revenue Market Share in 2021
Figure 43. Global Top 10 Players Prostate-specific Antigen (PSA) Testing Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Type in 2021
Figure 46. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Type (2023-2028)
Figure 47. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Application in 2021
Figure 48. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Application (2023-2028)
Figure 49. North America Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2017-2028)
Figure 50. North America Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2017-2028)
Figure 51. North America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country (2017-2028)
Figure 52. United States Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2017-2028)
Figure 56. Europe Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2017-2028)
Figure 57. Europe Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country (2017-2028)
Figure 58. Germany Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Prostate-specific Antigen (PSA) Testing Revenue Market Share by Region (2017-2028)
Figure 66. China Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2017-2028)
Figure 73. South America Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2017-2028)
Figure 74. South America Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Prostate-specific Antigen (PSA) Testing Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Prostate-specific Antigen (PSA) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
